Goris N - Search Results

1

A thiazepino[4,5-a]benzimidazole derivative hampers the RNA replication of Eurasian serotypes of foot-and-mouth disease virus.

Lefebvre DJ, De Vleeschauwer AR, Goris N, Van Borm S, Chimirri A, Monforte AM, Valdazo-Gonzalez B, King DP, Neyts J, De Clercq K. Lefebvre DJ, et al. Among authors: goris n. Biochem Biophys Res Commun. 2014 Dec 12;455(3-4):378-81. doi: 10.1016/j.bbrc.2014.11.023. Epub 2014 Nov 15. Biochem Biophys Res Commun. 2014. PMID: 25446115

2

Proof of concept for the inhibition of foot-and-mouth disease virus replication by the anti-viral drug 2'-C-methylcytidine in severe combined immunodeficient mice.

Lefebvre DJ, De Vleeschauwer AR, Goris N, Kollanur D, Billiet A, Murao L, Neyts J, De Clercq K. Lefebvre DJ, et al. Among authors: goris n. Transbound Emerg Dis. 2014 Dec;61(6):e89-91. doi: 10.1111/tbed.12069. Epub 2013 Mar 11. Transbound Emerg Dis. 2014. PMID: 23480064

3

A Refined Guinea Pig Model of Foot-and-Mouth Disease Virus Infection for Assessing the Efficacy of Antiviral Compounds.

De Vleeschauwer AR, Lefebvre DJ, Willems T, Paul G, Billiet A, Murao LE, Neyts J, Goris N, De Clercq K. De Vleeschauwer AR, et al. Among authors: goris n. Transbound Emerg Dis. 2016 Apr;63(2):e205-12. doi: 10.1111/tbed.12255. Epub 2014 Aug 28. Transbound Emerg Dis. 2016. PMID: 25164494

4

In vitro surrogate models to aid in the development of antivirals for the containment of foot-and-mouth disease outbreaks.

Osiceanu AM, Murao LE, Kollanur D, Swinnen J, De Vleeschauwer AR, Lefebvre DJ, De Clercq K, Neyts J, Goris N. Osiceanu AM, et al. Among authors: goris n. Antiviral Res. 2014 May;105:59-63. doi: 10.1016/j.antiviral.2014.02.009. Epub 2014 Feb 25. Antiviral Res. 2014. PMID: 24583031

5

Quantification of foot-and-mouth disease virus transmission rates using published data.

Goris NE, Eblé PL, de Jong MC, De Clercq K. Goris NE, et al. ALTEX. 2009;26(1):52-4. doi: 10.14573/altex.2009.1.52. ALTEX. 2009. PMID: 19326033 Free article.

6

Extending the foot-and-mouth disease module to the control of other diseases.

De Clercq K, Goris N. De Clercq K, et al. Among authors: goris n. Dev Biol (Basel). 2004;119:333-40. Dev Biol (Basel). 2004. PMID: 15742644 Review.

7

Quality assurance/quality control of foot and mouth disease solid phase competition enzyme-linked immunosorbent assay--Part I. Quality assurance: development of secondary and working standards.

Goris N, De Clercq K. Goris N, et al. Rev Sci Tech. 2005 Dec;24(3):995-1004. Rev Sci Tech. 2005. PMID: 16642770 Free article.

8

Foot-and-mouth disease virus: a first inter-laboratory comparison trial to evaluate virus isolation and RT-PCR detection methods.

Ferris NP, King DP, Reid SM, Hutchings GH, Shaw AE, Paton DJ, Goris N, Haas B, Hoffmann B, Brocchi E, Bugnetti M, Dekker A, De Clercq K. Ferris NP, et al. Among authors: goris n. Vet Microbiol. 2006 Oct 31;117(2-4):130-40. doi: 10.1016/j.vetmic.2006.06.001. Epub 2006 Jul 17. Vet Microbiol. 2006. PMID: 16846700

9

The importance of quality assurance/quality control of diagnostics to increase the confidence in global foot-and-mouth disease control.

De Clercq K, Goris N, Barnett PV, MacKay DK. De Clercq K, et al. Among authors: goris n. Transbound Emerg Dis. 2008;55(1):35-45. doi: 10.1111/j.1865-1682.2007.01011.x. Transbound Emerg Dis. 2008. PMID: 18397507

10

2'-C-methylcytidine as a potent and selective inhibitor of the replication of foot-and-mouth disease virus.

Goris N, De Palma A, Toussaint JF, Musch I, Neyts J, De Clercq K. Goris N, et al. Antiviral Res. 2007 Mar;73(3):161-8. doi: 10.1016/j.antiviral.2006.09.007. Epub 2006 Oct 10. Antiviral Res. 2007. PMID: 17055073

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters